Antineoplastic Combined Chemotherapy ProtocolsPatient Care TeamChemotherapy, AdjuvantCombined Modality TherapyNursing, TeamAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideNeoplasmsDrug Resistance, NeoplasmBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticFollow-Up StudiesAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungOvarian NeoplasmsNeoplasm MetastasisTime FactorsTesticular NeoplasmsVomitingTransplantation, AutologousNeutropeniaAdenocarcinomaHospital Rapid Response TeamNauseaLymphoma, Non-HodgkinRadiotherapy, AdjuvantProspective StudiesAntineoplastic Agents, PhytogenicHodgkin DiseaseColorectal NeoplasmsRadiotherapyClinical Trials as TopicAntibiotics, AntineoplasticDacarbazinePalliative CareNeoplasms, Germ Cell and EmbryonalCarmustineLomustineKaplan-Meier EstimateGranulocyte Colony-Stimulating FactorCamptothecinBrain NeoplasmsPlatinum CompoundsBone NeoplasmsInstitutional Management TeamsInfusions, Intra-ArterialOsteosarcomaDrug TherapyMelphalanLeukopeniaAntiemeticsMitomycinThiotepaHematopoietic Stem Cell TransplantationLiver NeoplasmsTumor Markers, BiologicalInfusions, IntravenousRecurrencePeritoneal NeoplasmsMitoxantroneLymphatic MetastasisDose-Response Relationship, DrugStomach NeoplasmsRandomized Controlled Trials as TopicTegafurAntibodies, Monoclonal, HumanizedGerminomaRadiotherapy DosageCell Line, TumorDaunorubicinCarcinoma, Squamous CellCarcinomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma